Lipocine Inc. (LPCN): Shares Outstanding

Annual figures by period end, from SEC filings.

Stock splits: 1-for-17, first reflected in a filing dated 2023-08-10. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2012-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

6.16M

As of 2025-12-31

8.24M

As of 2026-06-30

+5.6%

3-year compound annual growth

2011-12-31 Shares Outstanding (shares) 2025-12-31

Paler bars were last filed before a stock split, on the old share basis.

Period ended	Shares Outstanding	Change YoY	Source filing
2025-12-31	6.16M	+15.2%	2026-03-10, Balance as of period end
2024-12-31	5.35M	+0.6%	2026-03-10, Balance as of period end
2023-12-31	5.32M	+1.5%	2025-03-13, Balance as of period end
2022-12-31	5.23M	n/c	2024-03-07, Balance as of period end
2021-12-31	88.29M	+26.1%	2023-03-10, Balance as of period end
2020-12-31	70.04M	+86.0%	2022-03-09, Balance as of period end
2019-12-31	37.65M	+73.2%	2021-03-11, Balance as of period end
2018-12-31	21.73M	+2.2%	2020-03-13, Balance as of period end
2017-12-31	21.26M	+15.2%	2019-03-06, Balance as of period end
2016-12-31	18.46M	+1.2%	2018-03-12, Balance as of period end
2015-12-31	18.24M	n/c	2017-03-06, Balance as of period end
2014-12-31	12.79M	+1.0%	2016-03-10, Balance as of period end
2013-12-31	12.67M	+184.3%	2015-03-11, Balance as of period end
2012-12-31	4.46M	n/c	2014-03-31, Balance as of period end
2011-12-31	3.00M	n/a	2013-02-26, Balance as of period end